ABIO ARCA biopharma Inc.

0.46
-0.02  -4%
Previous Close 0.48
Open 0.47
Price To Book 0.85
Market Cap 6371649
Shares 13,924,058
Volume 3,440,386
Short Ratio
Av. Daily Volume 804,022

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial to be initiated 4Q 2019 under SPA subject to securing additional financing.
Gencaro
Chronic Heart Failure

SEC Filings

  1. 8-K - Current report 19617093
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 19589767
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19587847
  4. 424B5 - Prospectus [Rule 424(b)(5)] 19543033
  5. 8-K - Current report 19542713
  6. 8-K - Current report 181246529
  7. 8-K - Current report 181184607
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 181183697
  9. 8-K - Current report 181128484
  10. 8-K - Current report 181113827